I think this is one of those areas where if our adversaries get a significant breakthrough at any given moment, we could get way behind in a hurry.
Roy Blunt
The Public Record
Roy Blunt is an American politician currently serving as the senior United States senator from Missouri, a position he has held since January 2011. A member of the Republican Party, Blunt previously served as a United States Representative from 1997 to 2011. Throughout his career, he has focused on various issues including public health, research funding, and bipartisan cooperation in Congress.
I wholeheartedly disagree with the administration's removal of the longstanding Hyde Amendment.
when our good friend, Senator and then Director Coats, said you were never afraid to challenge the team, that was obviously an important thing for an IG anywhere.
I would not bet against this President, because he's so far done a pretty good job of hitting his marks.
I'd like to hear your thoughts about what kind of zero-based approach you might be willing to take to go back and look at those thousand jobs.
I do think that waiving the intellectual property rights on COVID-19 vaccines is a problem.
I believe if there was open dialogue and a stronger partnership between NCATS and CTSAs, there would likely be more buy-in from the community.
I would think here that some of the developmental issues, and they will be different with 4 and 5 year olds...
Members of this committee, most notably Senator Blunt, asked what NIH could do to ramp up innovation.
In a time of crisis, during shutdowns and social distancing, for a disease never seen before, the NIH and their nationwide system of grantees were able to use their expertise and infrastructure to develop tests, treatments, and vaccines…
Children, you know, have not--I think they are so important in terms of our Nation's future.
Well, let us know what we need to be thinking about as we think about the rest of this bill on that topic.
I mean, we know the impact in just the last half dozen years of immunotherapy on cancer treatment.
It appears to me that this change would bring uncertainty to the program and jeopardize the stability of the hubs.
I am concerned, specifically, with the proposal to break up hub awards into smaller pieces.
First, for the past six years, this Committee and Congress have prioritized and invested in NIH. Within this timeframe, funding for medical research increased by $12.85 billion, or nearly 43 percent, after having spent the previous decade…
I am a big supporter of the Clinical and Translational Science Award (CTSA) program.
I was watching Senator Ernst give this speech. And as to that ``Help Wanted'' sign, I thought I was back in Springfield, MO, my hometown, where I was this weekend. There were occasions when I was driving down a block, and I started looking…
I think one of the real strengths of the American higher education system since World War II has been virtually all of our programs, whether they were the GI benefit, or Pell Grants, or any other Federal Government program, you had the…
This has been a challenging year for all Americans, but especially those who work in public health.
The past 18 months have been challenging for our nation. The COVID-19 pandemic put unprecedented strain on our economy and its workforce.





